SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in SpringWorks Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- −2 vs. Q1 2021
- Shares held
- 44.7M
- +824.4K (+1.9%) vs. Q1 2021
- Total value
- $3.69B
- +$456.5M (+14.1%) vs. Q1 2021
- New holders
- 20
- 60 more added
- Sold out
- 22
- 36 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $47 |
| Q1 2026 | 1 | $47 |
| Q4 2025 | 2 | $2.18M |
| Q3 2025 | 3 | $2.16M |
| Q2 2025 | 223 | $3.65B |
| Q1 2025 | 306 | $3.29B |
| Q4 2024 | 216 | $2.92B |
| Q3 2024 | 226 | $2.59B |
| Q2 2024 | 209 | $2.91B |
| Q1 2024 | 217 | $3.85B |
| Q4 2023 | 180 | $2.75B |
| Q3 2023 | 147 | $1.58B |
| Q2 2023 | 142 | $1.82B |
| Q1 2023 | 149 | $1.70B |
| Q4 2022 | 137 | $1.73B |
| Q3 2022 | 148 | $1.80B |
| Q2 2022 | 144 | $1.36B |
| Q1 2022 | 136 | $2.79B |
| Q4 2021 | 144 | $2.82B |
| Q3 2021 | 142 | $2.86B |
| Q2 2021 | 135 | $3.69B |
| Q1 2021 | 137 | $3.23B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 140,834 | $11.6M | 0.08% | +4,955+3.6% | Added |
| Nuveen Asset Management, LLC | 162,521 | $13.4M | 0.00% | +69,521+74.8% | Added |
| Samsara BioCapital, LLC | 169,852 | $14.0M | 1.84% | 00.0% | Unchanged |
| Laurion Capital Management LP | 184,676 | $15.2M | 0.24% | −33,590−15.4% | Reduced |
| Goldman Sachs Group Inc | 185,753 | $15.3M | 0.00% | +45,766+32.7% | Added |
| Charles Schwab Investment Management Inc | 193,144 | $15.9M | 0.01% | +13,358+7.4% | Added |
| Sphera Funds Management Ltd. | 195,117 | $16.1M | 1.53% | +57,445+41.7% | Added |
| Ameriprise Financial Inc | 196,019 | $16.2M | 0.00% | +3,359+1.7% | Added |
| CIBC Asset Management Inc | 196,760 | $16.2M | 0.07% | +90,257+84.7% | Added |
| Bessemer Group Inc | 241,337 | $19.9M | 0.04% | −45,000−15.7% | Reduced |
| Price T Rowe Associates Inc | 308,937 | $25.5M | 0.00% | −18,742−5.7% | Reduced |
| Jennison Associates LLC | 313,659 | $25.8M | 0.02% | +128,574+69.5% | Added |
| Northern Trust Corp | 321,848 | $26.5M | 0.00% | +25,923+8.8% | Added |
| Massachusetts Financial Services Co | 392,842 | $32.4M | 0.01% | −1,147−0.3% | Reduced |
| Artal Group S.A. | 500,000 | $41.2M | 0.94% | +100,000+25.0% | Added |
| Geode Capital Management, LLC | 503,569 | $41.5M | 0.01% | +55,435+12.4% | Added |
| Norges Bank | 528,966 | $43.6M | 0.01% | +92,631+21.2% | Added |
| Deerfield Management Company, L.P. (Series C) | 558,574 | $46.0M | 0.82% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 563,468 | $46.4M | 0.09% | −4,467−0.8% | Reduced |
| Loomis Sayles & Co L P | 565,578 | $46.6M | 0.06% | −11,454−2.0% | Reduced |
| Pictet Asset Management Ltd | 636,236 | $52.4M | 0.06% | −108,999−14.6% | Reduced |
| Bank of America Corp | 772,462 | $63.7M | 0.01% | +271,908+54.3% | Added |
| Citadel Advisors LLC | 812,025 | $66.9M | 0.07% | +10,634+1.3% | Added |
| Victory Capital Management Inc | 872,562 | $71.9M | 0.07% | +27,297+3.2% | Added |
| State Street Corp | 1,081,921 | $89.2M | 0.00% | +2,353+0.2% | Added |
| ArrowMark Colorado Holdings LLC | 1,088,537 | $89.7M | 0.68% | −56,067−4.9% | Reduced |
| Consonance Capital Management LP | 1,199,339 | $98.8M | 11.89% | −2,060−0.2% | Reduced |
| Driehaus Capital Management LLC | 1,375,775 | $113.4M | 1.50% | +113,700+9.0% | Added |
| Boxer Capital, LLC | 2,075,905 | $171.1M | 6.04% | 00.0% | Unchanged |
| BlackRock Inc. | 2,486,323 | $204.9M | 0.01% | +216,785+9.6% | Added |
| Vanguard Group Inc | 2,706,067 | $223.0M | 0.01% | +212,011+8.5% | Added |
| FMR LLC | 3,968,220 | $327.0M | 0.03% | +176,852+4.7% | Added |
| Perceptive Advisors LLC | 4,849,912 | $399.7M | 5.20% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480.6M | 31.49% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,044,266 | $498.1M | 5.09% | −142,041−2.3% | Reduced |
| Caas Capital Management LP | 0 | $0 | 0.00% | −224,886−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −77,990−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −65,044−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −60,900−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −44,698−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −35,800−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −22,492−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −20,398−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −18,279−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −13,037−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −8,031−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −5,685−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3,499−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,478−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −988−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −695−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |